Impact Factor
3.81
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.47
674 total citations
h5-index
38
h5 depth signal
Cited share
80.8%
126 of 156
Total citations
674
Citation footprint
Metric signal
5.60
External metric anchor
Self-citation
1.9%
13 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
459
United Kingdom
156
Netherlands
86
Australia
79
Canada
73
Citing Fields of Research
Cardiology
473
Genetics & Genomics
450
Physiology
90
Lipids
84
Congenital Disorders
41
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
843
Articles tracked across the journal lifetime
Indexed publication set
156
126 cited publications
Last 12 months
95
11.9 publications/month
Open access share
34.7%
33 OA publications in the last year
Leading citing country
United States
459 citing publications
Leading citing field
Cardiology
473 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v11n1, Jan. 2018-
v11n1, Jan. 2018-
Research Focus & Classification
Indexed Subjects
Cardiology
Genetics & Genomics
Issuing & Sponsoring Bodies
issuing body
American Heart Association
Broad Categories
Cardiology
Genetics, Medical
Vascular Diseases
Genetics & Genomics
Lipids
Mass Spectrometry
MeSH Descriptors
Cardiovascular Diseases
Precision Medicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1161/hcg.0000000000000102
Open DOI
Standardization of Collected Biobank Data to Facilitate Cardiovascular Research: A Scientific Statement From the American Heart Association
Cardiovascular disease has been the focus of extensive biomedical research, yet it remains a leading cause of morbidity and mortality worldwide. One recent approach to support scientific discovery has been the development of large-scale ...
02
DOI 10.1161/circgen.126.005720
Open DOI
Bioactive Lipids of Cardiorespiratory Fitness Insights From Exercise Models in Humans, Mice, and Burmese Pythons
BACKGROUND: Cardiorespiratory fitness, commonly measured as peak oxygen consumption (peak VO 2 , is a strong predictor of cardiovascular health. Circulating lipids have been linked to exercise responses and metabolic adaptation, but the ...
03
DOI 10.1161/circgen.126.005782
Open DOI
Cardiologist-Delivered Genetic Testing in 482 Patients With Cardiomyopathy: The Infrastructure Needed for Mainstream Testing at Scale
BACKGROUND: Mainstream cardiac genetic testing, in which the treating cardiologist orders and returns multigene panel results without a traditional genetic counseling session, may expand access, but no mainstream program has quantified t...
04
DOI 10.1161/circgen.126.005733
Open DOI
FLNC -Related Cardiomyopathies in an Admixed Population: Expanding the Genotype-Phenotype Spectrum and Clinical Correlates
BACKGROUND: Pathogenic and likely pathogenic variants in filamin C ( FLNC ) cause a broad spectrum of cardiomyopathies. However, available genotype-phenotype data are derived predominantly from European and North American populations, wi...
05
DOI 10.1161/circgen.125.005691
Open DOI
Decoding Long Noncoding RNAs in Cardiac Development and Congenital Heart Disease: Recent Advances and Clinical Perspectives
Long noncoding RNAs (lncRNAs) have emerged as crucial regulators in cardiac development and congenital heart disease. With advances in high-throughput sequencing, single-cell omics, and epigenetic profiling, accumulating evidence suggest...
06
DOI 10.1161/circgen.125.005566
Open DOI
Personalized Nutrition for Hypertension: Current Evidence and Future Directions
Hypertension is a leading risk factor for cardiovascular disease, with lifestyle interventions, particularly diet, playing a pivotal role in its management. Recent advancements in personalized nutrition that tailor dietary recommendation...
07
DOI 10.1161/circgen.125.005514
Open DOI
Cardiovascular Genetic Counseling Is Associated With Improved Patient-Reported Outcomes Across Clinical Indications and Settings
BACKGROUND: Contemporary guidelines recommend genetic counseling for potentially inherited cardiomyopathies, channelopathies, aortopathies, and dyslipidemias, but few small studies characterize cardiovascular genetic counseling (CVGC) ou...
08
DOI 10.1161/circgen.125.005673
Open DOI
Pyrophosphatase 2 Deficiency: Clinical Presentation, Diagnosis and Management
BACKGROUND: PPA2 (pyrophosphatase 2) deficiency is a relatively newly recognized condition caused by biallelic variants in the PPA2 gene. The gene encodes the mitochondrial enzyme PPA2, involved in the production of orthophosphate in the...
09
DOI 10.1161/circgen.125.005376
Open DOI
Gene-Corrected Human iPSC–Derived Cardiomyocytes and Skeletal Muscles Reveal Partial Dystrophin Dp427 Preservation and Cardiac Dp116 Expression in Duchenne Muscular Dystrophy Patient With a Splice-Site Mutation in Intron 68 (c.9975-1G>T)
BACKGROUND: Duchenne muscular dystrophy (DMD) is a severe X-linked neuromuscular disease caused by mutations in the DMD gene, leading to the absence or dysfunction of dystrophin. Although cardiac and skeletal muscles are both affected, t...
10
DOI 10.1161/circgen.125.004307
Open DOI
Effects of Polygenic Risk Scores and Physical Activity on Blood Pressure Trajectories in Childhood, Adolescence, and Young Adulthood
BACKGROUND: Understanding the effects of genetics and lifestyle habits such as physical activity on blood pressure (BP) trajectories at an early age helps to improve understanding of the pathogenesis of hypertension over the life course....